Atractylodin Suppresses Fibrotic Scar Formation and Enhances Functional Recovery Following Spinal Cord Injury
Journal of Integrative Neuroscience · 2026
DOI: 10.31083/jin47565 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, 2026. Verfasst von Zhenwei Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, 230032 Hefei, Anhui, China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Recovery of Function, Cicatrix, Furans. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Fibrous scar formation significantly inhibits axonal regeneration and functional recovery following spinal cord injury (SCI). Atractylodin (ATD), an active constituent of traditional Chinese medicine, exhibits broad pharmacological properties, including anti-inflammatory and anti-fibrotic effects. Nevertheless, the potential therapeutic role of ATD in SCI and its underlying molecular mechanisms remain to be fully elucidated.
Methods
An SCI model was established in C57 mice. Motor function was assessed using the Basso Mouse Scale scoring system, inclined plane test, swimming test, and footprint analysis. Immunohistochemical staining was performed to evaluate fibrotic scar formation and neuronal survival. Western blotting and quantitative real-time PCR (qPCR) were also employed to investigate the molecular mechanisms underlying ATD-mediated regulation of fibroblasts following SCI.
Results
ATD administration significantly enhanced motor function in SCI mice, reduced the area of fibrotic scars, and suppressed the expression of fibrotic markers. Mechanistically, ATD inhibited Mothers Against Decapentaplegic Homolog 2/3 (SMAD2/3) phosphorylation and nuclear translocation, thereby suppressing fibroblast activation and extracellular matrix deposition, while promoting neuronal survival and axonal regeneration.
Conclusions
ATD mitigates fibrotic scar formation by targeting the Transforming Growth Factor Beta (TGF-β)/SMAD pathway, thereby facilitating axonal regeneration and functional recovery. This offers a promising therapeutic strategy for SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, 230032 Hefei, Anhui, China.
- Laboratory of Spinal and Spinal Cord Injury Regeneration and Repair, The First Affiliated Hospital of Anhui Medical University, 230032 Hefei, Anhui, China.
- Anhui Province Research Center for the Clinical Application of Digital Medical Technology, The First Affiliated Hospital of Anhui Medical University, 230022 Hefei, Anhui, China.
Zitieren
APA
Li, Z., Fang, C., Feng, C., Wu, Z., Zhao, C., & Shen, C. (2026). Atractylodin Suppresses Fibrotic Scar Formation and Enhances Functional Recovery Following Spinal Cord Injury. Journal of Integrative Neuroscience. https://doi.org/10.31083/jin47565
Vancouver
Li Z, Fang C, Feng C, Wu Z, Zhao C, Shen C. Atractylodin Suppresses Fibrotic Scar Formation and Enhances Functional Recovery Following Spinal Cord Injury. Journal of Integrative Neuroscience. 2026. doi:10.31083/jin47565
BibTeX
@article{Li2026,
author = {Li, Zhenwei and Fang, Chao and Feng, Chengcheng and Wu, Zuomeng and Zhao, Chenhao and Shen, Cailiang},
title = {Atractylodin Suppresses Fibrotic Scar Formation and Enhances Functional Recovery Following Spinal Cord Injury},
journal = {Journal of Integrative Neuroscience},
year = {2026},
doi = {10.31083/jin47565}
}
EUVIMED